Company Filing History:
Years Active: 2012-2013
Title: Brent A. Appleton: Innovator in Neuropilin Research
Introduction
Brent A. Appleton is a notable inventor based in San Francisco, CA (US). He has made significant contributions to the field of neuropilin research, holding a total of 2 patents. His work focuses on the structural biology of neuropilins and their therapeutic applications.
Latest Patents
Brent's latest patents include "Crystal structures of neuropilin fragments and neuropilin-antibody complexes." This invention provides crystal structures of neuropilin 1 (Nrp1) and neuropilin 2 (Nrp2) fragments, both alone and in complex with anti-neuropilin antibodies. It also outlines methods for their use and provides anti-Nrp antibodies along with methods for their therapeutic applications. Another patent is titled "Anti-pan neuropilin antibody and binding fragments thereof," which similarly details the crystal structures of neuropilin fragments and their therapeutic applications.
Career Highlights
Brent A. Appleton is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative research and development in pharmaceuticals. His work at Genentech has allowed him to further his research in neuropilin and contribute to advancements in medical therapies.
Collaborations
Brent has collaborated with notable colleagues, including Christian Wiesmann and Yan Wu. Their combined expertise has enhanced the research and development of neuropilin-related therapies.
Conclusion
Brent A. Appleton's contributions to neuropilin research and his innovative patents highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in therapeutic applications.